MariMed Inc. (MRMD.CN)
CAD 0.14
(-17.65%)
CAD 0.14
(-17.65%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 23.65 Million USD | -26.84% |
| 2022 | 26.04 Million USD | -4.07% |
| 2021 | 29.65 Million USD | 78.72% |
| 2020 | 16.71 Million USD | 188.81% |
| 2019 | -20.11 Million USD | -613.55% |
| 2018 | -2.81 Million USD | -674.96% |
| 2017 | 490.34 Thousand USD | -47.5% |
| 2016 | 877.47 Thousand USD | 318.0% |
| 2015 | -434.33 Thousand USD | 46.27% |
| 2014 | -797.34 Thousand USD | -37.31% |
| 2013 | -535.6 Thousand USD | 21.53% |
| 2012 | -740.03 Thousand USD | -100.06% |
| 2011 | -369.91 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 4.1 Million USD | -6.66% |
| 2024 Q1 | 4.42 Million USD | 180.06% |
| 2023 Q2 | 4.11 Million USD | -8.13% |
| 2023 Q4 | 5.2 Million USD | 101.43% |
| 2023 Q1 | 4.48 Million USD | -35.44% |
| 2023 Q3 | 2.58 Million USD | -37.2% |
| 2023 FY | - USD | -26.84% |
| 2022 Q1 | 8.06 Million USD | 304.47% |
| 2022 Q3 | 7.25 Million USD | 49.86% |
| 2022 Q4 | 6.93 Million USD | -4.33% |
| 2022 FY | - USD | -4.07% |
| 2022 Q2 | 4.84 Million USD | -40.01% |
| 2021 Q2 | 13.49 Million USD | 54.52% |
| 2021 Q4 | 1.99 Million USD | -74.09% |
| 2021 Q1 | 8.73 Million USD | 4.34% |
| 2021 FY | - USD | 78.72% |
| 2021 Q3 | 7.69 Million USD | -42.97% |
| 2020 FY | - USD | 188.81% |
| 2020 Q1 | 1.6 Million USD | 102.08% |
| 2020 Q2 | 3.02 Million USD | 88.55% |
| 2020 Q3 | 4.86 Million USD | 60.94% |
| 2020 Q4 | 8.37 Million USD | 72.06% |
| 2019 Q1 | 2.29 Million USD | -76.44% |
| 2019 Q4 | -77.28 Million USD | -5805.96% |
| 2019 Q3 | -1.3 Million USD | -115.73% |
| 2019 FY | - USD | -613.55% |
| 2019 Q2 | 8.31 Million USD | 261.87% |
| 2018 Q2 | -5.27 Million USD | -2090.27% |
| 2018 Q4 | 9.75 Million USD | 238.22% |
| 2018 Q1 | -240.85 Thousand USD | 58.9% |
| 2018 FY | - USD | -674.96% |
| 2018 Q3 | -7.05 Million USD | -33.77% |
| 2017 FY | - USD | -47.5% |
| 2017 Q4 | -586.06 Thousand USD | -671.11% |
| 2017 Q1 | 299.74 Thousand USD | -44.45% |
| 2017 Q2 | 694.7 Thousand USD | 131.76% |
| 2017 Q3 | 102.61 Thousand USD | -85.23% |
| 2016 Q1 | 70.84 Thousand USD | -64.86% |
| 2016 FY | - USD | 318.0% |
| 2016 Q4 | 539.58 Thousand USD | 278.13% |
| 2016 Q3 | 142.69 Thousand USD | -22.39% |
| 2016 Q2 | 183.85 Thousand USD | 159.54% |
| 2015 Q1 | -282.43 Thousand USD | 41.79% |
| 2015 Q3 | 12.94 Thousand USD | 103.59% |
| 2015 FY | - USD | 46.27% |
| 2015 Q4 | 201.58 Thousand USD | 1457.15% |
| 2015 Q2 | -360.51 Thousand USD | -27.64% |
| 2014 Q4 | -485.2 Thousand USD | -404.73% |
| 2014 FY | - USD | -37.31% |
| 2014 Q3 | -96.13 Thousand USD | 2.16% |
| 2014 Q2 | -98.25 Thousand USD | 31.53% |
| 2014 Q1 | -143.5 Thousand USD | 17.37% |
| 2013 Q3 | -106.42 Thousand USD | 16.93% |
| 2013 Q4 | -173.65 Thousand USD | -63.17% |
| 2013 FY | - USD | 21.53% |
| 2013 Q1 | -172.47 Thousand USD | 56.64% |
| 2013 Q2 | -128.11 Thousand USD | 25.72% |
| 2012 Q3 | -161.97 Thousand USD | -21.19% |
| 2012 Q4 | -397.79 Thousand USD | -145.6% |
| 2012 Q2 | -133.64 Thousand USD | -186.67% |
| 2012 Q1 | -46.62 Thousand USD | 0.0% |
| 2012 FY | - USD | -100.06% |
| 2011 Q2 | -266.95 Thousand USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q3 | -98.35 Thousand USD | 63.16% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aion Therapeutic Inc. | -6.07 Million CAD | 489.45% |
| Ayurcann Holdings Corp. | -2.01 Million CAD | 1276.528% |
| Blueberries Medical Corp. | -1.22 Million CAD | 2036.014% |
| The BC Bud Corporation | -1.19 Million CAD | 2077.736% |
| BioNxt Solutions Inc. | -6.48 Million CAD | 464.771% |
| CordovaCann Corp. | -1.6 Million CAD | 1575.96% |
| Christina Lake Cannabis Corp. | -2.62 Million CAD | 1001.637% |
| Captor Capital Corp. | 2.42 Million CAD | -876.966% |
| City View Green Holdings Inc. | -2.01 Million CAD | 1274.21% |
| 1CM Inc. | 1.31 Million CAD | -1700.802% |
| Global Hemp Group Inc. | -24.79 Thousand CAD | 95505.961% |
| Greenway Greenhouse Cannabis Corporation | -2.2 Million CAD | 1171.095% |
| IM Cannabis Corp. | -2.79 Million CAD | 947.814% |
| Lobe Sciences Ltd. | -4.4 Million CAD | 637.312% |
| Maple Leaf Green World Inc. | -392.21 Thousand CAD | 6130.861% |
| Mountain Valley MD Holdings Inc. | -3.19 Million CAD | 840.808% |
| Nextleaf Solutions Ltd. | 1.14 Million CAD | -1972.002% |
| Ovation Science Inc. | -778.83 Thousand CAD | 3137.112% |
| Pharmadrug Inc. | -1.33 Million CAD | 1871.818% |
| Captiva Verde Wellness Corp. | -6.05 Million CAD | 490.583% |
| RAMM Pharma Corp. | -6.3 Million CAD | 475.336% |
| RIV Capital Inc. | -20.28 Million CAD | 216.635% |
| Revive Therapeutics Ltd. | -5.59 Million CAD | 522.77% |
| Red White & Bloom Brands Inc. | -77.59 Million CAD | 130.485% |
| SLANG Worldwide Inc. | -2.95 Million CAD | 901.636% |
| 1933 Industries Inc. | -10.03 Million CAD | 335.763% |
| Red Light Holland Corp. | -5.25 Million CAD | 550.05% |
| Top Strike Resources Corp. | -767.99 Thousand CAD | 3179.976% |
| Xebra Brands Ltd. | -1.49 Million CAD | 1682.212% |
| Adastra Holdings Ltd. | -1.41 Million CAD | 1776.086% |